Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells

Mutagenesis

Volumn 20, Issue 2, 2005, Pages 139-146

  Olivero, Ofelia A ^a,c   Tejera, Agueda M ^b   Fernandez, Juan J ^a   Taylor, Barbara J ^a   Das, Shreyasi ^a   Divi, Rao L ^a   Poirier, Miriam C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSIDAD NACIONAL DE QUILMES   (Argentina)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS DNA; CYCLIN A; CYCLIN A2; CYCLIN D1; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; LAMIVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANALYSIS OF VARIANCE; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL VIABILITY; CONTROLLED STUDY; DOSE RESPONSE; DOWN REGULATION; DRUG MECHANISM; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; MITOSIS; MULTIPLE DRUG DOSE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UPREGULATION;

ANTI-HIV AGENTS; BASE SEQUENCE; CELL CYCLE; DNA; DNA ADDUCTS; GENE EXPRESSION; HELA CELLS; HUMANS; LAMIVUDINE; MUTAGENS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE INHIBITORS; S PHASE; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 18344371833     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/gei019     Document Type: Article

References (28)

1. IARC. (2000) IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. World Health Organization. IARC Scientific Publications No. 76, IARC, Lyon, France, pp. 1-521.
2. Olivero,O.A., Beland,F.A. and Poirier,M.C. (1994) Immunofluorescent localization and quantitation of 3′-azido-2′, 3′- dideoxythymidine (AZT) incorporated into chromosomal DNA of human, hamster and mouse cell lines. Int. J. Oncol., 4, 49-54.
3. Olivero,O.A., Anderson,L.M., Diwan,B.A. et al. (1997) Transplacental effects of 3′-azido-2′,3′-dideoxythymidine (AZT): tumorigenicity in mice and genotoxicity in mice and monkeys. J. Natl Cancer Inst., 89, 1602-1608.
4. Olivero,O.A., Shearer,G.M., Chougnet,C.A. et al. (1999) Incorporation of zidovudine into leukocyte DNA from HIV-1-positive adults and pregnant women, and cord blood from infants exposed in utero. AIDS, 13, 919-925.
5. Gomez,D.E., Kassim,A. and Olivero,O.A. (1995) Preferential incorporation of 3′-azido-2′,3′-dideoxythymidine (AZT) in telomeric sequences of CHO cells. Int. J. Oncol., 7, 1057-1060.
6. Shafik,H.M., Nokta,M.A. and Pollard,R.B. (1991) Recombinant human interferon beta ser protects against zidovudine-induced genetic damage in AIDS patients. Antiviral Res., 16, 205-212.
7. Olivero,O.A., Beland,F.A., Fullerton,N.F. and Poirier,M.C. (1994) Vaginal epithelial DNA damage and expression of preneoplastic markers in mice during chronic dosing with tumorigenic levels of 3′-azido-2′,3′- dideoxythymidine (AZT). Cancer Res., 54, 6235-6242.
8. Sussman,H.E., Olivero,O.A., Meng,Q., Pietras,S.M., Poirier,M.C., O'Neill,J.P., Finette,B.A., Bauer,M.J. and Walker,V.E. (1999) Genotoxicity of 3′-azido-3′-deoxythymidine in the human lymphoblastoid cell line, TK-6: relationships between DNA incorporation, mutant frequency, and spectrum of deletion mutations in HPRT. Mutat. Res., 429, 249-259.
9. Meng,Q., Walker,D.M., Olivero,O.A., Shi,X., Antiochos,B.B., Poirier,M.C. and Walker,V.E. (2000) Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells. Proc. Natl Acad. Sci. USA, 97, 12667-12671.
10. Robbins,B.L., Tran,T.T., Pinkerton,F.H.,Jr, Akeb,F., Guedj,R., Grassi,J., Lancaster,D. and Fridland,A. (1998) Development of a new cartridge radioimmunoassay for determination of intracellular levels of lamivudine triphosphate in the peripheral blood mononuclear cells of human immunodeficiency virus-infected patients. Antimicrob. Agents Chemother., 42, 2656-2660.
11. Maytin,E.V., Ubeda,M., Lin,J.C. and Habener,J.F. (2001) Stress-inducible transcription factor CHOP/gadd153 induces apoptosis in mammalian cells via p38 kinase-dependent and -independent mechanisms. Exp. Cell Res., 267, 193-204.
12. Ubeda,M. and Habener,J.F. (2003) CHOP transcription factor phosphorylation by casein kinase 2 inhibits transcriptional activation. J. Biol. Chem., 278, 40514-40520.
13. Johnson,D.G. and Walker,C.L. (1999) Cyclins and cell cycle checkpoints. Annu. Rev. Pharmacol. Toxicol., 39, 295-312.
14. Poirier,M.C., Olivero,O.A., Walker,D.M. and Walker,V.E. (2004) Perinatal genotoxicity and carcinogenicity of anti-retroviral nucleoside analog drugs. Toxicol. Appl. Pharmacol., 199, 151-161.
15. Olivero,O.A., Fernandez,J.J., Antiochos,B.B., Wagner,J.L., St Claire,M.E. and Poirier,M.C. (2002) Transplacental genotoxicity of combined antiretroviral nucleoside analogue therapy in Erythrocebus patas monkeys. J. Acquir. Immune Defic. Syndr., 29, 323-329.
16. Escobar,P.A., Olivero,O.A., Day,B.W., Tice,R.R.,Romkes,M., Day,R. D. and Bigbee, W.L. (2001) AZT-induced DNA damage detected by the comet assay. Environ. Mol. Mutagen., 37(Suppl. 32), 30.
17. Chandrasekaran,B., Kute,T.E. and Duch,D.S. (1995) Synchronization of cells in the S phase of the cell cycle by 3′-azido-3′- deoxythymidine: implications for cell cytotoxicity. Cancer Chemother. Pharmacol., 35, 489-495.
18. Wu,Y.W., Xiao,Q., Jiang,Y.Y., Fu,H. and Zhao,F. (2004) Synthesis, in vitro anticancer evaluation and interference with cell cycle progression of N-phosphoamino acid esters of zidovudine and stavudine. Nucleosides Nucleotides Nucleic Acids, 23, 1797-1811.
19. Viora,M., Di Genova,G., Rivabene,R., Malorni,W. and Fattorossi,A. (1997) Interference with cell cycle progression and induction of apoptosis by dideoxynucleoside analogs. Int. J. Immunopharmacol., 19, 311-321.
20. Luch,A. (2002) Cell cycle control and cell division: implications for chemically induced carcinogenesis. Chembiochem., 3, 506-516.
21. Vermeulen,K., Van Bockstaele,D.R. and Berneman,Z.N. (2003) The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif., 36, 131-149.
22. 2 arrest after DNA damage. Science, 282, 1497-1501.
23. Sakoff,J.A. and Ackland,S.P. (2000) Thymidylate synthase inhibition induces S phase arrest, biphasic mitochondrial alterations and caspase-dependent apoptosis in leukaemia cells. Cancer Chemother. Pharmacol., 46, 477-487.
24. Sherr,C.J. and Roberts,J.M. (2004) Living with or without cyclins and cyclin-dependent kinases. Genes Dev., 18, 2699-2711.
25. Gladden,A.B. and Diehl,J.A. (2003) Cell cycle progression without cyclin E/CDK2: breaking down the walls of dogma. Cancer Cell, 4, 160-162.
26. Roberts,J.M. and Sherr,C.J. (2003) Bared essentials of CDK2 and cyclin E. Nat. Genet., 35, 9-10.
27. Geng,Y., Yu,Q., Sicinska,E., Das,M., Schneider,J.E., Bhattacharya,S., Rideout, W.M. III, Bronson,R.T., Gardner,H. and Sicinski,P. (2003) Cyclin E ablation in the mouse. Cell, 114, 431-443.
28. Ghosh,A.K., Jana,S., Das,T., Sa,G., Mandal,N. and Ray,P.K. (1999) Protection by protein A of apoptotic cell death caused by anti-AIDS drug zidovudine. Biochem. Biophys. Res. Commun., 264, 601-604.